Stockscreener 앱 받기
84.12
1.27%
1.05
전일 마감가:
$83.07
열려 있는:
$83.05
하루 거래량:
3.07M
Relative Volume:
0.69
시가총액:
$49.40B
수익:
$5.88B
순이익/손실:
$1.34B
주가수익비율:
35.86
EPS:
2.3455
순현금흐름:
$577.90M
1주 성능:
+2.35%
1개월 성능:
+9.15%
6개월 성능:
+11.20%
1년 성능:
+26.56%
1일 변동 폭
$82.89
$84.83
1주일 범위
$80.24
$87.09
52주 변동 폭
$64.89
$87.09
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
EW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
84.14 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
|
ABT
Abbott Laboratories
|
125.52 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
363.34 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.31 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-29 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-10-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
| 2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
Edwards Lifesciences (NYSE:EW) Given New $90.00 Price Target at Truist Financial - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Bank of New York Mellon Corp - MarketBeat
Wellington Shields Capital Management LLC Sells 5,700 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
EPO and UPC align in decision to uphold Edwards Lifesciences’ heart valve patent - JUVE Patent
36,530 Shares in Edwards Lifesciences Corporation $EW Purchased by Burney Co. - MarketBeat
Envestnet Asset Management Inc. Has $26.61 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Truist Securities Maintains Edwards Lifesciences (EW) Rating, Ra - GuruFocus
Will Edwards Lifesciences Corporation (EWL) stock test record highs in 2025 - newser.com
Bernstein Adjusts Price Target on Edwards Lifesciences to $90 From $85 - MarketScreener
Is Edwards Lifesciences Corporation (EWL) stock positioned for secular growth2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Bernstein raises Edwards Lifesciences stock price target to $90 on TAVR growth - Investing.com
Canaccord Genuity raises Edwards Lifesciences stock price target on solid Q3 - Investing.com
Raymond James upgrades Edwards Lifesciences stock rating to Outperform By Investing.com - Investing.com Canada
Machina Capital S.A.S. Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Welch & Forbes LLC - MarketBeat
Edwards Lifesciences Corporation $EW Shares Bought by Telos Capital Management Inc. - MarketBeat
South Dakota Investment Council Has $13.38 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Can Edwards Lifesciences Corporation stock sustain institutional interestInsider Selling & Weekly High Return Stock Opportunities - newser.com
Will Edwards Lifesciences Corporation stock outperform foreign stocksJuly 2025 Highlights & Fast Entry High Yield Tips - newser.com
Raymond James upgrades Edwards Lifesciences stock rating to Outperform - Investing.com
How Edwards Lifesciences Corporation stock reacts to new regulations2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com
Can Edwards Lifesciences Corporation stock survive global slowdownMarket Performance Recap & Consistent Profit Alerts - newser.com
Strs Ohio Grows Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Amalgamated Bank Has $8.86 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation stock trend forecast2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
Edwards Lifesciences Corporation (NYSE:EW) Q3 2025 Earnings Call Transcript - Insider Monkey
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences' (EW) Overweight Rating Reaffirmed at Piper Sandler - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00 at Royal Bank Of Canada - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00 - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $92.00 - MarketBeat
Mccarter Private Wealth Services LLC Reduces Position in Edwards Lifesciences Corporation $EW - MarketBeat
Lockheed Martin Investment Management Co. Has $4.34 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Fisher Funds Management LTD Has $74.16 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Using data models to predict Edwards Lifesciences Corporation stock movementWeekly Trend Summary & Risk Controlled Stock Pick Alerts - newser.com
Spire Wealth Management Raises Position in Edwards Lifesciences Corporation $EW - MarketBeat
What is the fair value of Edwards Lifesciences Corporation stock nowJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Quantitative breakdown of Edwards Lifesciences Corporation recent moveMarket Performance Report & Weekly Sector Rotation Insights - newser.com
Edwards Lifesciences Topped Estimates As Demand For Heart Devices Rose - Finimize
Edwards Lifesciences Reports Strong Earnings and Growth - TipRanks
Edwards Lifesciences (NYSE:EW) Updates Q4 2025 Earnings Guidance - MarketBeat
Edwards Lifesciences (NYSE:EW) Announces Quarterly Earnings Results - MarketBeat
Edwards Lifesciences Lifts Outlook After Topping Expectations - Finimize
Edwards Lifesciences’ ALTERRA Study: A Potential Game-Changer in Heart Valve Treatment - TipRanks
Edwards Lifesciences (EW) Target Price Raised by Barclays to $99 - GuruFocus
Citigroup Raises Price Target for Edwards Lifesciences (EW) to $96 | EW Stock News - GuruFocus
Edwards Lifesciences (EW): Analyst Updates and Raised Price Targ - GuruFocus
Goldman Sachs Raises Price Target for Edwards Lifesciences (EW) to $104 | EW Stock News - GuruFocus
Canaccord Genuity Raises Edwards Lifesciences' Price Target to $84 From $81 - MarketScreener
Piper Sandler Raises Edwards Lifesciences (EW) Price Target to $95 | EW Stock News - GuruFocus
RBC Capital Raises Price Target for Edwards Lifesciences (EW) to $95.00 | EW Stock News - GuruFocus
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.19%
3.18%
자본화:
|
볼륨(24시간):